Related Experiment Videos
Effects of BCG revaccination on asthma
1Department of Internal Medicine, Chonnam National University Medical School and Research Institute of Medical Sciences, Gwangju, Korea.
Allergy
|November 18, 2003
Summary
Repeated Bacille Calmette-Guérin (BCG) vaccination may improve lung function in asthma patients. Revaccination showed enhanced Th1 immune response, suggesting potential for asthma therapy.
Area of Science:
- Immunology
- Pulmonology
- Vaccinology
Background:
- Bacille Calmette-Guérin (BCG) vaccination has previously demonstrated efficacy in suppressing human asthma.
- The Th1 immune response is implicated in the therapeutic effects of BCG for asthma.
Purpose of the Study:
- To investigate the impact of revaccination with BCG on lung function in asthma patients.
- To determine if repeated BCG vaccination further enhances immune responses compared to a single vaccination.
Main Methods:
- A study involving two groups: one receiving repeated BCG vaccination and another receiving a single BCG vaccination (previously placebo).
- Lung function was assessed over time.
- Peripheral blood samples were analyzed for immune markers, specifically the interferon gamma/interleukin 4 ratio.
Main Results:
- Lung function showed a tendency to improve in the Repeated BCG group compared to baseline.
- The Single BCG group did not show significant lung function improvement compared to baseline.
- Repeated BCG vaccination led to a significant increase in the peripheral blood interferon gamma/interleukin 4 ratio.
Conclusions:
- Repeated BCG vaccination may offer further improvements in lung function for asthma patients.
- The enhanced Th1 immune response observed in the Repeated BCG group supports its potential as an asthma therapy.
- Further research into repeated BCG vaccination protocols for asthma management is warranted.